Mim8

DRUG2 trials

Sponsors

Novo Nordisk A/S

Conditions

Haemophilia AHaemophilia A With InhibitorsHaemophilia A With or Without Inhibitors

Phase 3

A Research Study Looking at Mim8 in Children With Haemophilia A With or Without Inhibitors

CompletedNCT05306418

Novo Nordisk A/SHaemophilia A With or Without Inhibitors

Start: 2022-04-04End: 2024-11-13Updated: 2025-11-13

A Research Study Looking at Long-term Treatment With Mim8 in People With Haemophilia A

Active, not recruitingNCT05685238

Novo Nordisk A/SHaemophilia A, Haemophilia A With Inhibitors

Start: 2023-02-13End: 2028-06-30Target: 451Updated: 2026-09-09

Related Papers

Denecimig (Mim8) prophylaxis once-every-2-weeks for hemophilia A with or without inhibitors - 26-week results from FRONTIER

Blood Advances2026-07-17

Mim8 prophylaxis in adults and adolescents with hemophilia A: 52-week efficacy and safety outcomes from the phase 3 FRONTIER2 study

Blood2025-11-03

Safety and Efficacy of Mim8 Prophylaxis Administered Once Every Two Weeks for Patients with Hemophilia A with or without Inhibitors: Interim Analysis of the FRONTIER4 Open-Label Extension Study

Blood2024-11-05

Mim8 Clinical Development Program: An Overview of the Frontier Studies

Blood2022-11-156 citations